172 results
8-K
EX-10.3
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
, specifications, drawings, blueprints, sketches, materials, photographs, charts, and any other documents and property, and reproductions of any
8-K
EX-10.1
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
at all levels;
Work with the Lead Director in determining the matters and materials that should be presented to the Board;
Develop and recommend
8-K
EX-99.1
APTO
Aptose Biosciences Inc
26 Mar 24
Aptose Reports Results for the Fourth Quarter and Full Year 2023
4:04pm
clinical trial, our healthy volunteer trial, manufacturing activities to support clinical development, purchase of clinical trial materials, and related
8-K
EX-1.1
ymq 56na9jmlr
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
424B4
6nd epn0j0bk8
26 Jan 24
Prospectus supplement with pricing info
5:30pm
8-K
EX-99.1
z8k8nwkiou325 kotyv
6 Sep 23
Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
8:01am
424B3
ffe8wkjocaxsfmb1d
6 Jul 23
Prospectus supplement
4:01pm
S-1
7zadxprilwhy
16 Jun 23
IPO registration
6:42pm
8-K
EX-10.1
rw8 ntwlzeh
26 May 23
Entry into a Material Definitive Agreement
4:01pm